Trials / Completed
CompletedNCT02933112
Workflow Validation of an In-home Auto-titrating Mandibular Positioner
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- Zephyr Sleep Technologies · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to test the workflow of an auto-titrating mandibular positioner in its intended setting. Participants with obstructive sleep apnea will use the device to determine their eligibility for oral appliance therapy and provide feedback on usability of the device.
Detailed description
One treatment for obstructive sleep apnea is oral appliance therapy during sleep, in which an appliance that covers the upper and lower teeth acts to pull the lower jaw forward, opening the throat passage and allowing for normal breathing. However, oral appliance therapy does not treat sleep apnea effectively in all individuals. In order to identify those individuals for whom oral appliance therapy will work, the study sponsor has developed an investigational device called an auto-titrating mandibular positioner. The device automatically pulls the lower jaw forward in response to respiratory events while the individual sleeps. Study participants will learn the outcome of their sleep tests and will provide feedback on the ease of use of the device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Auto-titrating mandibular positioner test | Participants will undergo a theragnostic test using the auto-titrating mandibular positioner to determine if they are eligible candidates to use oral appliance therapy for their obstructive sleep apnea. The device works by moving the lower jaw forward in response to respiratory events while the participant sleeps. All participants will undergo the same test. |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-09-04
- Completion
- 2018-10-11
- First posted
- 2016-10-14
- Last updated
- 2018-10-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02933112. Inclusion in this directory is not an endorsement.